The US Food and Drug Administration has issued a Complete Response Letter for ivonescimab plus platinum-based chemotherapy in EGFR-mutated advanced non-small-cell lung cancer following EGFR tyrosine kinase inhibitor treatment. Announced […]
Want to stay in touch with the latest updates from Oncology News, Insights, Stories by OncoDaily? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.
Reading your RSS feed has never been easier!
Website title: Oncology News, Insights, Stories by OncoDaily